Considering the surgical margins used in TORS, is it necessary to cover the entire tongue base with an elective dose in IMRT of cT1-3 HPV+ squamous cell carcinoma grossly involving one side of the base of tongue?
For instance, VMAT planning can sometimes deliver very low doses to the contralateral base of tongue. Do you worry about this? What is your approach?
How would you address nodal coverage?
Answer from: Radiation Oncologist at Academic Institution
Frankly, I see no point in doing TORS if a patient is likely to require postop RT unless you believe that you can safely treat neck only (which includes unavoidably part of the ipsilateral oropharynx to irradiate the RP nodes). And I do not (but have been wrong before).
Particularly HPV positive no...
Comments
Radiation Oncologist at HCA South Atlantic Completely agree. A large number of poorly selecte...
Radiation Oncologist at West Virginia University I believe a recently published trial designed to d...
Answer from: Radiation Oncologist at Academic Institution
While it is a question of how rigorously the details of ECOG 3311 protocol were followed, and there remains further debate whether primary site coverage is necessary if the only risk is the neck, the protocol specifically discouraged large volumes:
"5.1.11.2 Guidelines for Target Volume Delineation...
Answer from: Radiation Oncologist at Community Practice
I was asked to update the responses, and after review, I'm not sure much has changed since the excellent responses above, beginning in 2020.
In general, the field is progressively more comfortable with tighter margins around gross tumor when delivering definitive chemoRT. The margins are tighter in...
Answer from: Radiation Oncologist at Community Practice
I do not electively include the entire tongue base in Post-TORS RT planning. I use contrast enhanced simulation CT with a narrow field of view (for better tissue delineation) to outline the surgical bed. Having said that, it is not always easy to delineate surgical bed with 100% conviction. In those...
Comments
Radiation Oncologist at USC Keck School of Medicine Thanks @Anand K. Sharma. Do you follow similar vol...
Answer from: Radiation Oncologist at Academic Institution
Almost certainly not as long as margins are 2 mm+ - the AVOID-RT study showed excellent local control when omitting the primary site completely (though when covering the RP space primary site still gets some dose) when margins >2 mm - Swisher-McClure et al., PMID 31785337. Our institutional data ...
Comments
Radiation Oncologist at Northeast Georgia Health System Other than margins, what pathological factors do y...
Answer from: Radiation Oncologist at Community Practice
Thank you for your responses so far. I would like to disclose that I asked the question.
Practice certainly varies on expansions (i.e., GTVp->CTVp->PTV, just GTVp->PTV, intermediate dose expansion [sometimes called PTVp2], no intermediate dose, etc). If I may clarify my question:
During d...
Comments
Radiation Oncologist at Vanderbilt-Ingram Cancer Center It is variation in practice. Some folks cover the ...
Radiation Oncologist at Tennessee Oncology Fair points and thanks for your time. Food for tho...
Radiation Oncologist at Vanderbilt-Ingram Cancer Center Thanks for the link, glad to see it being evaluate...
Completely agree. A large number of poorly selecte...
I believe a recently published trial designed to d...